Literature DB >> 16688834

Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis.

Manuel Romero-Gomez1, Maria Jover, Daniel Diaz-Gomez, Laura-Collantes de Teran, Regina Rodrigo, Ines Camacho, Miriam Echevarria, Vicente Felipo, Juan-D Bautista.   

Abstract

AIM: To assess whether portacaval anastomosis (PCA) in rats affects the protein expression and/or activity of glutaminase in kidneys, intestines and in three brain areas of cortex, basal ganglia and cerebellum and to explain the neurological alterations found in hepatic encephalopathy (HE).
METHODS: Sixteen male Wistar rats weighing 250-350 g were grouped into sham-operation control (n=8) or portacaval shunt (n=8). Twenty-eight days after the procedure, the animals were sacrificed. The duodenum, kidney and brain were removed, homogenised and mitochondria were isolated. Ammonia was measured in brain and blood. Phosphate-activated glutaminase (PAG) activity was determined by measuring ammonia production following incubation for one hour at 37 celsius degree with O-phthalaldehyde (OPA) and specific activity expressed in units per gram of protein (mukat/g of protein). Protein expression was measured by immunoblotting.
RESULTS: Duodenal and kidney PAG activities together with protein content were significantly higher in PCA group than in control or sham-operated rats (duodenum PAG activity was 976.95+/-268.87 mukat/g of protein in PCA rats vs 429.19+/-126.92mukat/g of protein in sham-operated rats; kidneys PAG activity was 1259.18+/-228.79 mukat/g protein in PCA rats vs 669.67+/-400.8 mukat/g of protein in controls, P<0.05; duodenal protein content: 173% in PCA vs sham-operated rats; in kidneys the content of protein was 152% in PCA vs sham-operated rats). PAG activity and protein expression in PCA rats were higher in cortex and basal ganglia than those in sham-operated rats (cortex: 6646.6+/-1870.4 mukat/g of protein vs 3573.8+/-2037.4 mukat/g of protein in control rats, P<0.01; basal ganglia, PAG activity was 3657.3+/-1469.6 mukat/g of protein in PCA rats vs 2271.2+/-384 mukat/g of protein in sham operated rats, P<0.05; In the cerebellum, the PAG activity was 2471.6+/-701.4 mukat/g of protein vs 1452.9+/-567.8 mukat/g of protein in the PCA and sham rats, respectively, P<0.05; content of protein: cerebral cortex: 162%+/-40% vs 100%+/-26%, P<0.009; and basal ganglia: 140%+/-39% vs 100%+/-14%, P<0.05; but not in cerebellum: 100%+/-25% vs 100%+/-16%, P=ns).
CONCLUSION: Increased PAG activity in kidney and duodenum could contribute significantly to the hyperammonaemia in PCA rats, animal model of encephalopathy. PAG is increased in non-synaptic mitochondria from the cortex and basal ganglia and could be implicated in the pathogenesis of hepatic encephalopathy. Therefore, PAG could be a possible target for the treatment of HE or liver dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16688834      PMCID: PMC4088079          DOI: 10.3748/wjg.v12.i15.2406

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

Review 1.  Renal metabolism of amino acids: its role in interorgan amino acid exchange.

Authors:  Marcel C G van de Poll; Peter B Soeters; Nicolaas E P Deutz; Kenneth C H Fearon; Cornelis H C Dejong
Journal:  Am J Clin Nutr       Date:  2004-02       Impact factor: 7.045

2.  Activation of N-methyl-D-aspartate receptors in rat brain in vivo following acute ammonia intoxication: characterization by in vivo brain microdialysis.

Authors:  C Hermenegildo; P Monfort; V Felipo
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

Review 3.  Glutamine as a pathogenic factor in hepatic encephalopathy.

Authors:  J Albrecht; M Dolińska
Journal:  J Neurosci Res       Date:  2001-07-01       Impact factor: 4.164

4.  Dispelling myths in the treatment of hepatic encephalopathy.

Authors:  Debbie Shawcross; Rajiv Jalan
Journal:  Lancet       Date:  2005 Jan 29-Feb 4       Impact factor: 79.321

5.  Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis.

Authors:  Sherzad Balata; Steven W M Olde Damink; Karen Ferguson; Ian Marshall; Peter C Hayes; Nicolaas E p Deutz; Roger Williams; Joanna Wardlaw; Rajiv Jalan
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

Review 6.  Role of mitochondrial glutaminase in rat renal glutamine metabolism.

Authors:  N P Curthoys
Journal:  J Nutr       Date:  2001-09       Impact factor: 4.798

Review 7.  Glutamine synthetase activity and glutamine content in brain: modulation by NMDA receptors and nitric oxide.

Authors:  Elena Kosenko; Marta Llansola; Carmina Montoliu; Pilar Monfort; Regina Rodrigo; Mariluz Hernandez-Viadel; Slaven Erceg; Ana M Sánchez-Perez; Vicente Felipo
Journal:  Neurochem Int       Date:  2003 Sep-Oct       Impact factor: 3.921

8.  Induction of the mitochondrial permeability transition in cultured astrocytes by glutamine.

Authors:  K V Rama Rao; A R Jayakumar; M D Norenberg
Journal:  Neurochem Int       Date:  2003 Sep-Oct       Impact factor: 3.921

9.  Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.

Authors:  Steven W M Olde Damink; Rajiv Jalan; Doris N Redhead; Peter C Hayes; Nicolaas E P Deutz; Peter B Soeters
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

10.  Glutamine-induced free radical production in cultured astrocytes.

Authors:  Arumugam R Jayakumar; K V Rama Rao; Arne Schousboe; Michael D Norenberg
Journal:  Glia       Date:  2004-05       Impact factor: 7.452

View more
  7 in total

Review 1.  Role of astrocytes in brain function and disease.

Authors:  Marta Sidoryk-Wegrzynowicz; Michal Wegrzynowicz; Eunsook Lee; Aaron B Bowman; Michael Aschner
Journal:  Toxicol Pathol       Date:  2010-11-12       Impact factor: 1.902

Review 2.  Energy metabolism in brain cells: effects of elevated ammonia concentrations.

Authors:  Leif Hertz; Geeta Kala
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

3.  The liver, the brain and nitrogen metabolism.

Authors:  Piero Amodio
Journal:  Metab Brain Dis       Date:  2008-12-24       Impact factor: 3.584

4.  Current concepts in the pathophysiology and management of hepatic encephalopathy.

Authors:  R Todd Frederick
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

5.  Hepatic encephalopathy therapy: An overview.

Authors:  Oliviero Riggio; Lorenzo Ridola; Chiara Pasquale
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-04-06

6.  Acute liver failure in rats activates glutamine-glutamate cycle but declines antioxidant enzymes to induce oxidative stress in cerebral cortex and cerebellum.

Authors:  Santosh Singh; Papia Mondal; Surendra K Trigun
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

7.  A novel score predicts mortality after transjugular intrahepatic portosystemic shunt: MOTS - Modified TIPS Score.

Authors:  Luisa Fürschuß; Florian Rainer; Maria Effenberger; Markus Niederreiter; Rupert H Portugaller; Angela Horvath; Peter Fickert; Vanessa Stadlbauer
Journal:  Liver Int       Date:  2022-04-01       Impact factor: 8.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.